Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The 10-Ks have been audited by Warren Averett, LLC since 2007.
Technicals don't take into account catalysts and biotechs are catalyst driven. Within just the next month or two Cytodyn has a large list of catalysts coming down and your technicals will be shown to be useless.
But you promised us $1.60, now I'm disappointed.
Lawsuits by the 5 firms weren't dropped, they never existed.
Emergency Use Approval is not based on a standard BLA timeline.
74 days to either accept or reject. Once interim COVID-19 trial results are released and the spotlight is on Cytodyn, HIV BLA rejection without extremely good cause would blow up in the FDA's face. The last thing the FDA wants is an investigation into how the FDA held back a no SAE, no resistance HIV drug for years.
The moment the FDA accepts the BLA filing for HIV they're stuck. If they deny approval it goes in front of an independent review board.
I think there's a distinct possibility that stocks go up and down.
Phantom shares are naked shorts that are never covered, still exist in the system and can artificially and unofficially inflate the O/S.
https://www.thekomisarscoop.com/2020/03/how-phantom-shares-on-wall-street-threaten-u-s-companies-and-investors/
Naked shorting often occurs because of lack of shares or cost to borrow shares. Cytodyn has hit both in recent months. It doesn't look like a large number of naked shorts are occurring with Cytodyn but it wouldn't surprise me if a few brokerages are offering naked shorts to keep that extra borrow cost for themselves.
Failure to deliver for Cytodyn stock in April 2020 - 18,197.444 shares.
https://www.sec.gov/data/foiadocsfailsdatahtm
Did QAnon tell you so?
A conspiracy theorist covering for another conspiracy theorist is quite circular but par for the course in that milieu.
Just fine.
Spot on! I keep running into new ones to check. Latest addition for the list - Alopecia Areata.
Why would you omit that we're going head to head against remdesivir?
I'll let you in on a little secret the FDA approves drugs not CEOs.
COVID-19 approval within two months sets everything right.
The rationale is that of the greater good. A few people could be helped now under compassionate use but it would slow down trial enrollment. Many more could be helped if this was widely commercially available. It does bode well for fast FDA approval on interim data.